Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Yinchuan
Clinical trial register · China

Clinical Trials in Yinchuan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Beijing 5582 Shanghai 3880 Guangzhou 3354 Hangzhou 1824 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
General Hospital of Ningxia Medical University20 Xijing Hospital7 Novartis Pharmaceuticals3 Tang-Du Hospital1 Peking University Third Hospital1
Site location
Beijing5582 Shanghai3880 Guangzhou3354 Hangzhou1824 Wuhan1342
All 625 locations
Target enrolment
to

Trials with a site in Yinchuan

47 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Epidural Hydroxyethyl Starch for Post-Dural Puncture Headache in Parturients
NCT07914790Parturients, Accidental Puncture of Dura During Anaesthesia, Epidural Filling, Hydroxyethyl Starch
Peking University First Hospital
Observational
410
Beijing, Yinchuan, Taiyuan
2026-11-04
By invitation
General Hospital of Ningxia Medical University
Observational
300
Yinchuan
2026-09-22
Not yet open
General Hospital of Ningxia Medical University
Not applicable
80
Yinchuan
2026-09-01
Not yet open
Combined Interval Training and Scenario Simulation for ALS Training of Medical Students
NCT07239531Advanced Life Support Operational Skills and Theoretical Knowledge Learning and Memorization
General Hospital of Ningxia Medical University
Not applicable
48
Yinchuan
2026-09-01
Not yet open
General Hospital of Ningxia Medical University
Not applicable
130
Yinchuan
2026-09
Recruiting
Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
Phase 3
550
Baoding, Cangzhou, Shijiazhuang, Zhangjiakou, Baotou, Chifeng, Yinchuan, Jinan
2026-08-18
Recruiting
General Hospital of Ningxia Medical University
Not applicable
84
Yinchuan
2026-08-01
Not yet open
Development and Validation of a Colorectal Cancer Diagnostic Model
NCT07692555Colorectal Cancer, Advanced Neoplasia, Prediction Models, Risk Stratification
Peking University Cancer Hospital & Institute
Observational
20,000
Beijing, Fuzhou, Xiamen, Yinchuan
2026-07-15
Recruiting
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
NCT07670923Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
DrugsCiprofol·Propofol
General Hospital of Ningxia Medical University
Phase 4
108
Yinchuan
2026-07-01
Recruiting
Qilu Hospital of Shandong University
Not applicable
274
Xingyi, Yinchuan, Jinan, Linqing
2026-07-01
Not yet open
General Hospital of Ningxia Medical University
Not applicable
96
Yinchuan
2026-06-25
Not yet open
General Hospital of Ningxia Medical University
Not applicable
208
Yinchuan
2026-06-23
Recruiting
General Hospital of Ningxia Medical University
Observational
80
Yinchuan
2026-06-16
Not yet open
General Hospital of Ningxia Medical University
Not applicable
80
Yinchuan
2026-06-10
Recruiting
General Hospital of Ningxia Medical University
Not applicable
100
Yinchuan
2026-05-20
Recruiting
General Hospital of Ningxia Medical University
Not applicable
1,617
Yinchuan
2026-05-08
Recruiting
General Hospital of Ningxia Medical University
Not applicable
960
Yinchuan
2026-04-22
Recruiting
Amgen
Phase 3
406
Beijing, Zhengzhou, Changsha, Nanjing, Yinchuan, Xi'an, Jinan
2026-03-23
Recruiting
General Hospital of Ningxia Medical University
Not applicable
100
Yinchuan
2026-03-20
Recruiting
General Hospital of Ningxia Medical University
Not applicable
184
Yinchuan
2026-03-12
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
NCT07553754Prostate Cancer (Diagnosis), Bone Metastasis, PSMA PET, Liquid Biopsy
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Weinan, Xi'an, Xianyang, Xining, Yan’an
2026-03-12
Recruiting
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2026-03-03
Recruiting
Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants
NCT07045844Very Preterm Infant, Necrotizing Enterocolitis (NEC)
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
2,324
Guilin, Yulin, Zhengzhou, Wuhan, Yiyang, Hohhot, Ganzhou, Yinchuan
2026-01-23
Recruiting
Hepatopancreatobiliary Surgery Institute of Gansu Province
Not applicable
120
Lanzhou, Qinhuangdao, Shenyang, Yinchuan, Xi’an
2026-01-07
Not yet open
Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach
NCT07366853Adverse Effect, Feasibility Study, Safety and Effectiveness
General Hospital of Ningxia Medical University
Not applicable
200
Yinchuan
2026-01-01
By invitation
Synergistic Effect of Intravenous Lidocaine on Anesthetic Induction and Emergence in Patients Undergoing Laparoscopic Cholecystectomy or Gynecological Surgery
NCT07193836Cholecystectomy, Laparoscopic, Gynecologic Surgical Procedures, Anesthesia and Procedure Related Time Intervals
DrugLidocaine
General Hospital of Ningxia Medical University
Not applicable
195
Yinchuan
2025-09-25
Active, closed
A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases
NCT06786338IgA Nephropathy (IgAN), C3 Glomerulopathy, IC-MPGN
DrugSGB-9768
Suzhou Sanegene Bio Inc.
Phase 2
45
Beijing, Changsha, Chengdu, Guiyang, Hangzhou, Shanghai, Yangzhou, Yinchuan
2025-06-06
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Yinchuan, Jining, Xian, Beijing, Shanghai
2025-04-30
Recruiting
The Effect of VitC on IVF Outcome of DOR Patients
NCT06794047Diminished Ovarian Reserve, IVF Outcomes
Peking University Third Hospital
Not applicable
1,100
Beijing, Shijiazhuang, Yinchuan, Xi’an, Shenzhen
2025-03-17
Recruiting
Lepu Medical Technology (Beijing) Co., Ltd.
Not applicable
213
Beijing, Chongqing, Xiamen, Lanzhou, Shenzhen, Zhengzhou, Hohhot, Yinchuan
2025-02-25
Recruiting
Tang-Du Hospital
Phase 2
27
Changsha, Yinchuan, Xi'an
2025-02-18
Active, closed
Queen's University, Belfast
Not applicable
10,000
Shenyang, Yinchuan
2024-11-28
Recruiting
General Hospital of Ningxia Medical University
Not applicable
80
Yinchuan
2024-11-01
Recruiting
General Hospital of Ningxia Medical University
Observational
50
Yinchuan
2024-10-01
Recruiting
General Hospital of Ningxia Medical University
Not applicable
100
Yinchuan
2024-08-01
Recruiting
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
NCT06342167Locally Advanced Esophageal Squamous Cell Carcinoma, Sintilimab, Radiotherapy, Concurrent Chemoradiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
57
Beijing, Fujian, Handan, Anyang, Xinxiang, Yinchuan, Feixian, Jining
2024-03-14
Recruiting
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
NCT06221722Constipation - Functional, Refractory Constipation, Fluoxetine, fMRI
DrugFluoxetine
Xijing Hospital of Digestive Diseases
Observational
150
Yinchuan, Xi'an
2023-11-01
Recruiting
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2/3
374
Fuzhou, Guangzhou, Guiyang, Anyang, Luoyang, Pingxiang, Changchun, Yinchuan
2023-04-24
Recruiting
AstraZeneca
Phase 2
163
Beijing, Hangzhou, Harbin, Hefei, Kunming, Wuhan, Yinchuan, Zhengzhou
2023-01-16
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Wuhan, Nanjing, Yinchuan, Taiyuan, Hangzhou, Wenzhou, Beijing, Shanghai
2021-12-13
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Beijing, Guangzhou, Luoyang, Zhengzhou, Changsha, Changchun, Yinchuan, Taiyuan
2021-09-20
Recruiting
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086Renal Cancer, Metastases, PSMA PET
Xijing Hospital
Not applicable
300
Lanzhou, Yinchuan, Xining, Xi'an, Weinan, Xianyang, Yan’an
2021-06-01
Recruiting
Xijing Hospital
Observational
1,700
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
By invitation
Xijing Hospital
Not applicable
1,600
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
NCT07553780High-risk Prostate Cancer, PSMA PET, Treatment Response, Therapy Monitoring
Xijing Hospital
Observational
110
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-07
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
NCT07531329Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-05
Active, closed
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
NCT02221999Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
DrugsTaxol·Letrozole·Paclitaxel·Cisplatin
RenJi Hospital
Phase 2/3
250
Shenzhen, Handan, Hengyang, Hohhot, Kunshan, Yinchuan, Shanghai, Zhoushan
2013-09
Rows per page Showing 1–47 of 47
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/yinchuan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 47 of those studies with a site in Yinchuan.

How many clinical trials are recruiting in Yinchuan?

31 of the 47 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 8 have not yet opened recruitment, 5 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yinchuan), 47 studies
PhaseStudiesRecruitingShare
Not applicable241451.1%
Observational11923.4%
Phase 35310.6%
Phase 2438.5%
Phase 2/3214.3%
Phase 4112.1%

Most active sponsors

Lead sponsors with the most studies (Yinchuan)
Lead sponsorStudiesRecruiting
General Hospital of Ningxia Medical University2011
Xijing Hospital76
Novartis Pharmaceuticals31
Amgen11
AstraZeneca11
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.11
Hepatopancreatobiliary Surgery Institute of Gansu Province11
Lepu Medical Technology (Beijing) Co., Ltd.11
Peking University Cancer Hospital & Institute10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.